Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid to reduce blood transfusion in femur fracture patients
2018-000528-32Phase 4Active
- Sponsor
- Parc de Salut Mar
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hip fracture, Neck Of Femur Fracture and Not applicable comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Primary: Reduction in transfusion rate. Started Apr 2018; status: active.
02
Drugs
tranexamic acid
03
Conditions
hip fractureNeck Of Femur FractureNot applicable
Beyond the preview
Go deeper on 2018-000528-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000528-32.